Sensor
    42.
    发明授权
    Sensor 有权

    公开(公告)号:US11313821B2

    公开(公告)日:2022-04-26

    申请号:US16626888

    申请日:2018-06-28

    Inventor: Huijun Zhao

    Abstract: A sensor for the in situ detection of a target chemical species, comprising a gas permeable membrane having a sampling side and an opposing analytical side, wherein the sampling side of the membrane is capable of receiving a sample and the membrane is permeable to target chemical species present in the sample. A weak acid or a weak base is in contact with the analytical side of the membrane, and a conductivity detector is in contact with the weak acid or weak base. In use, target chemical species present in the sample permeate through the membrane and react with the weak acid or weak base, producing ionic species and changing the conductivity.

    COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE

    公开(公告)号:US20220062402A1

    公开(公告)日:2022-03-03

    申请号:US17416271

    申请日:2019-12-20

    Abstract: This invention relates generally to polynucleotides, polypeptides, compositions, methods and uses for eliciting an immune response to Neisseria, methods for immunizing a subject against a Neisseria infection, and methods for preventing and/or treating a Neisseria infection in a subject. More particularly, the invention relates to antigenic Neisseria polypeptides and encoding polynucleotides, and related uses and methods, including use for preparing compositions and medicaments for eliciting an immune response to Neisseria, for immunizing a subject against a Neisseria infection, and for preventing and/or treating a Neisseria infection in a subject. The invention also relates to methods for producing therapeutic anti-Neisseria antigen-binding molecules, and therapeutic uses of those antigen-binding molecules.

    BIOMARKERS AND USES THEREFOR
    48.
    发明申请

    公开(公告)号:US20250101525A1

    公开(公告)日:2025-03-27

    申请号:US18730665

    申请日:2023-01-23

    Abstract: Disclosed herein are biomarkers of cancer. More particularly, the present disclosure relates to miRNA biomarkers and their use in methods, compositions, apparatuses, devices and kits for determining an indicator that is useful for assessing a likelihood that oropharyngeal cancer is present or absent in a human subject, or for assessing a likelihood of a human subject with OPC having a poor survival prognosis or good survival prognosis.

Patent Agency Ranking